{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:08:40Z","timestamp":1790982520861,"version":"4.1.0"},"reference-count":11,"publisher":"Wiley","issue":"16","license":[{"start":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004331","name":"Johnson and Johnson","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["acsjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cancer"],"published-print":{"date-parts":[[2025,8,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The incidence of prostate cancer in the United States has steadily risen since 2014, which has reversed decades of progress toward lowering the burden of prostate cancer. Mortality rates have plateaued, despite reliable screening methodology in the form of prostate\u2010specific antigen testing, and despite a recent surge in the number of approved therapeutics for the management of primary and metastatic prostate cancer. If these trends are not addressed quickly and decisively via a multidisciplinary approach, loss of life and economic strain due to prostate cancer could precipitously increase in the coming years. To this end, the American Cancer Society (ACS) convened a collaborative of experts across the prostate cancer continuum to identify barriers to progress and generate opportunities for innovation. Through\u00a0a series of consensus\u2010building exercises and progressive refinement of themes into actionable priority areas, the collaborative identified three strategic priorities. These priorities form the backbone of an action plan to improve risk assessment and screening uptake, optimize therapeutic intervention for localized prostate cancer, and leverage the emerging arsenal of tools to more effectively manage advanced prostate cancer in the clinic. To advance this work, the ACS has launched the ACS National Prostate Cancer Roundtable to nucleate and coordinate partners from across the prostate cancer continuum to activate around these strategic priorities, and to build momentum toward improving prostate cancer outcomes for all.<\/jats:p>","DOI":"10.1002\/cncr.70010","type":"journal-article","created":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T16:49:06Z","timestamp":1754758146000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Consensus\u2010built recommendations to improve prostate cancer outcomes: A summary of the American Cancer Society Prostate Cancer Collaborative"],"prefix":"10.1002","volume":"131","author":[{"given":"Jessie","family":"Sanders","sequence":"first","affiliation":[{"name":"American Cancer Society  Atlanta Georgia USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caleb","family":"Levell","sequence":"additional","affiliation":[{"name":"American Cancer Society  Atlanta Georgia USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1996-3292","authenticated-orcid":false,"given":"Lucas J.","family":"Brand","sequence":"additional","affiliation":[{"name":"American Cancer Society  Atlanta Georgia USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William L.","family":"Dahut","sequence":"additional","affiliation":[{"name":"American Cancer Society  Atlanta Georgia USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8799-6749","authenticated-orcid":false,"given":"Yaw A.","family":"Nyame","sequence":"additional","affiliation":[{"name":"Department of Urology University of Washington School of Medicine  Seattle Washington USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorelei","family":"Mucci","sequence":"additional","affiliation":[{"name":"American Cancer Society  Atlanta Georgia USA"},{"name":"Department of Epidemiology Harvard T.H. Chan School of Public Health  Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William K.","family":"Oh","sequence":"additional","affiliation":[{"name":"Medical Oncology and Hematology Yale School of Medicine  New Haven Connecticut USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"American Cancer Society Prostate Cancer Collaborative","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,8,9]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055\u20109965.epi\u201022\u20101038"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2022.11.023"},{"key":"e_1_2_9_4_1","volume-title":"Cancer Facts & Figures 2025","author":"American Cancer Society","year":"2025"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21871"},{"key":"e_1_2_9_6_1","unstructured":"American Association for Cancer Research.CancerDisparitiesProgressReport.org [Internet].American Association for Cancer Research;2024. Accessed February 1 2025.http:\/\/www.CancerDisparitiesProgressReport.org\/"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1057\/s41271\u2010024\u201000502\u20104"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2024.06.022"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2004.12.021"},{"key":"e_1_2_9_10_1","volume-title":"Closing Gaps in Cancer Screening: Connecting People, Communities, and Systems to Improve Equity and Access. A Report From the President\u2019s Cancer Panel to the President of the United States","author":"President's Cancer Panel","year":"2022"},{"key":"e_1_2_9_11_1","volume-title":"What Is Design Thinking (DT)?"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/evidoa2300289"}],"updated-by":[{"DOI":"10.1002\/cncr.70105","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000}}],"container-title":["Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncr.70010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T01:45:28Z","timestamp":1760406328000},"score":1,"resource":{"primary":{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/cncr.70010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,9]]},"references-count":11,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2025,8,15]]}},"alternative-id":["10.1002\/cncr.70010"],"URL":"https:\/\/doi.org\/10.1002\/cncr.70010","archive":["Portico"],"relation":{"correction":[{"id-type":"doi","id":"10.1002\/cncr.70105","asserted-by":"object"}]},"ISSN":["0008-543X","1097-0142"],"issn-type":[{"value":"0008-543X","type":"print"},{"value":"1097-0142","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,9]]},"assertion":[{"value":"2025-08-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70010"}}